Aug 6, 2026 07:00AM
Aug 3, 2026 07:00AM
Aug 3, 2026 07:00AM
Jul 9, 2026 07:02AM
Jul 9, 2026 07:00AM
Jul 6, 2026 12:06PM
Jul 6, 2026 12:05PM B.Riley on Opus Genetics (IRD): 'we remain buyers'
Jul 6, 2026 07:01AM
Jul 6, 2026 07:00AM
Jun 23, 2026 06:40AM
Jun 17, 2026 04:19AM
May 12, 2026 07:00AM
May 5, 2026 04:21AM
May 4, 2026 04:30PM Opus Genetics gets FDA acceptance for gene therapy into rare disease program
May 4, 2026 04:30PM
May 4, 2026 10:14AM
Apr 10, 2026 06:59AM
Mar 10, 2026 07:00AM
Feb 25, 2026 06:59AM
Feb 25, 2026 06:59AM
Jan 20, 2026 05:06AM BTIG Starts Opus Genetics (IRD) at Buy
Jan 8, 2026 07:07AM
Jan 8, 2026 07:00AM
Nov 12, 2025 07:00AM
Nov 6, 2025 07:03AM
Nov 6, 2025 07:01AM
Nov 6, 2025 07:00AM
Nov 6, 2025 07:00AM Opus Genetics Announces Successful FDA Meeting Supporting Advancement of OPGx-LCA5 Toward Pivotal Trial for LCA5-Related Inherited Retinal Disease
Oct 1, 2025 06:55AM
Sep 30, 2025 07:00AM
Sep 30, 2025 07:00AM
Sep 4, 2025 08:00AM
Sep 4, 2025 08:00AM
Aug 18, 2025 08:01AM
Aug 18, 2025 08:00AM Opus Genetics Announces FDA Clearance of IND Application for Gene Therapy Candidate OPGx-BEST1
Aug 13, 2025 04:30PM
Aug 5, 2025 08:00AM
Jul 23, 2025 08:00AM
Jul 3, 2025 04:30PM
Jun 26, 2025 06:56AM
Jun 26, 2025 06:55AM
Jun 23, 2025 08:00AM Opus Genetics Awarded Non-Dilutive Funding from the RD Fund to Support Preclinical Development of OPGx-MERTK Program
Jun 2, 2025 08:00AM
Jun 2, 2025 08:00AM
May 15, 2025 08:00AM
May 12, 2025 08:00AM
May 6, 2025 08:03AM
May 6, 2025 08:00AM
May 5, 2025 08:00AM Opus Genetics Announces Presentation of OPGX-LCA5 Gene Therapy Data at ARVO; 12 Month Phase 1/2 Results Support Potential to Restore to Meaningful Vision
Apr 15, 2025 10:36AM

328,147 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All